Your browser doesn't support javascript.
loading
Phase I trial of RV3-BB rotavirus vaccine: a human neonatal rotavirus vaccine.
Danchin, M; Kirkwood, C D; Lee, K J; Bishop, R F; Watts, E; Justice, F A; Clifford, V; Cowley, D; Buttery, J P; Bines, J E.
Affiliation
  • Danchin M; RV3 Rotavirus Vaccine Program, Murdoch Childrens Research Institute, Parkville, Victoria, Australia. margie.danchin@rch.org.au
Vaccine ; 31(23): 2610-6, 2013 May 28.
Article in En | MEDLINE | ID: mdl-23597719

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 / 3_ND Database: MEDLINE Main subject: Rotavirus Infections / Rotavirus / Rotavirus Vaccines Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Adult / Child / Female / Humans / Infant / Male Language: En Journal: Vaccine Year: 2013 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 / 3_ND Database: MEDLINE Main subject: Rotavirus Infections / Rotavirus / Rotavirus Vaccines Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Adult / Child / Female / Humans / Infant / Male Language: En Journal: Vaccine Year: 2013 Document type: Article